{
    "code": "01039694",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01039694",
    "time": "2020-11-20 10:01:59",
    "許可證字號": "衛署藥製字第039694號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/01\/08",
    "發證日期": "85\/01\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103969407",
    "中文品名": "達梭黴素凍晶注射劑",
    "英文品名": "TAZOCIN LYO-INJECTION",
    "適應症": "ＰＩＰＥＲＡＣＩＬＬＩＮ具有感受性、以及對ＰＩＰＥＲＡＣＩＬＬＩＮ具抗藥性但對ＰＩＰＥＲＡＣＩＬＬＩＮ？ＴＡＺＯＢＡＣＴＡＭ有感受性之Ｂ－ＬＡＣＴＡＭＡＳＥ產生菌株所引起之中至嚴重程度感染",
    "劑型": "243凍晶注射劑",
    "包裝": "2.25公克,4.5公克小瓶 100支以下支裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PIPERACILLIN (SODIUM), TAZOBACTAM (AS SODIUM)",
    "限制項目": "01國　產",
    "申請商名稱": "1504402200  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "6133081157  美商輝瑞健康生醫股份有限公司台灣分公司新竹廠",
            "製造廠廠址": "新竹縣新豐鄉中崙村中崙290之1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30041010104 人用醫藥製劑，含青黴素類或具有青黴素酸結構之衍生物者Medicaments, containing penicillins or derivatives thereof,with a penicillanic acid structure, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812691910",
            "成分名稱": "PIPERACILLIN (SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "4.0000000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4410000710",
            "成分名稱": "TAZOBACTAM (AS SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "500.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0812691910",
            "成分名稱": "PIPERACILLIN (SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "2.0000000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4410000710",
            "成分名稱": "TAZOBACTAM (AS SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "250.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0812691910",
            "成分名稱": "PIPERACILLIN (SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "4.0000000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4410000710",
            "成分名稱": "TAZOBACTAM (AS SODIUM)",
            "含量描述": "(POTENCY)",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "為白色至微黃色之滅菌凍晶粉末",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Tazocin 實體外觀 (藥商變更)-109-09-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=003&Type=10"
        },
        {
            "title": "Tazocin vial with barcode-109-01-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=002&Type=10"
        },
        {
            "title": "Tazocin Lyo-Injection 達梭黴素 MA 039694實體-104-09-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tazocin Lyo-Injection LLD USPI 201811-2 (藥商變更)-109-09-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=024&Type=9"
        },
        {
            "title": "02 039694 0001-108-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=023&Type=9"
        },
        {
            "title": "02 039694 0001-107-04-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=022&Type=9"
        },
        {
            "title": "02 039694 0001-106-06-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=021&Type=9"
        },
        {
            "title": "02 039694 0001-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=020&Type=9"
        },
        {
            "title": "020396940001-105-09-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=019&Type=9"
        },
        {
            "title": "Tazocin 外盒包裝 (藥商變更)-109-09-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=010&Type=8"
        },
        {
            "title": "4.5 瓶子外觀1040910-104-10-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039694&Seq=009&Type=8"
        }
    ]
}